Clinical Trial Update: Post Marketing Surveillance for ADACEL™ in South Korea [Phase 4]

View source ↗

Summary

Phase 4 post-marketing surveillance study for ADACEL™ in South Korea evaluating diphtheria, tetanus, and pertussis in real-world use; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Diphtheria, Tetanus | Phase 4 | Status: COMPLETED | Results posted: 2017-01-04